Sales and Marketing

Showing 15 posts of 11524 posts found.

Patients on Enbrel work longer, says study

September 7, 2009 Research and Development, Sales and Marketing Enbrel, RA

 Rheumatoid arthritis patients taking Enbrel are able to keep working for longer, according to a new study comparing its affects …

Head-to-head boost for Brilinta over Plavix

September 4, 2009 Research and Development, Sales and Marketing AZ, Brillinta

 AstraZeneca has released details of its brand Brilinta’s performance in head-to-head trials with Plavix, the world’s second biggest-selling drug.Earlier this …

Roche’s MabThera expands licence in leukaemia

September 4, 2009 Research and Development, Sales and Marketing MabThera, Roche

 MabThera has been approved in Europe for use in previously treated chronic lymphocytic leukaemia, which Roche says will offer new …

Merck launches Saflutan in first European markets

September 4, 2009 Research and Development, Sales and Marketing Merck, ophthalmology

Merck's glaucoma drug Saflutan has been launched in the UK and Spain. The manufacturer says more launches are planned in …

Novartis swine-flu jab effective in single dose

September 3, 2009 Manufacturing and Production, Research and Development, Sales and Marketing Novartis, h1n1

A study of Novartis' pandemic swine-flu jab shows it is potentially protective after just one dose, which could help eke …

Pharmafocus expands into Europe

September 3, 2009 Research and Development, Sales and Marketing Europe

 The September issue of Pharmafocus marks a new stage in the publication’s development with an expanded monthly circulation that takes …

Merck unveils post-merger leadership team

September 3, 2009 Research and Development, Sales and Marketing MA, Merck

The make-up of Merck and Schering-Plough's new corporate entity became clearer this week. Referred to as the 'new Merck' and …

Pfizer shamed with $2.3bn fine for marketing fraud

September 3, 2009 Sales and Marketing Pfizer, US, illegal, off label prescribing

The US government has imposed a $2.3 billion fine on Pfizer for a string of offences including illegal off-label prescribing …

New cancer cases set to hit 17 million by 2020

September 2, 2009 Research and Development, Sales and Marketing Cancer, healthcare

The next ten years will see a 30% leap in the number of new cancer cases across the world, according …

UCB and Novartis expand alliance in Germany

September 1, 2009 Sales and Marketing Germany, Novartis, UCB

UCB and Novartis have extended their partnership in Germany with a new licensing deal for the cardiovascular and diabetes drug …

Shire goes for early approval in Gaucher disease

September 1, 2009 Research and Development, Sales and Marketing Gaucher's, Shire

Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …

Pradaxa data boosts Boehringer

September 1, 2009 Research and Development, Sales and Marketing Boehringer, Pradaxa

Boehringer Ingelheim has unveiled new positive data for its blood-thinner Pradaxa, showing it reduces the risk of stroke compared to …

Pfizer agrees price cut in Clinton deal

September 1, 2009 Research and Development, Sales and Marketing HIV, Pfizer, price cuts

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

Indian government accepts pro-patent report

September 1, 2009 Research and Development, Sales and Marketing Asia, India, patents

The government of India has accepted the findings of a report into its patent laws, which recommends maintaining a higher …
The Gateway to Local Adoption Series

Latest content